Estratégias corporativas: diversificação com criação de valor estudo de caso de duas empresas farmacêuticas brasileiras
Autor(a) principal: | |
---|---|
Data de Publicação: | 2010 |
Tipo de documento: | Dissertação |
Idioma: | por |
Título da fonte: | Repositório Institucional do FGV (FGV Repositório Digital) |
Texto Completo: | http://hdl.handle.net/10438/6670 |
Resumo: | As one can see the pharmaceutic market has been showing a rather competitive and rich profile on account of different questions that involve economics, financial marketing aspects, researches and development not only relate to the population health, but it is gifted by high profits and the dominancy in most multinational enterprises in the Brazilian scenary. This study brings as a proposal to analyse two Brazilian laboratories and their ways in accomplishing the diversification strategy on their business and avaliating the creation of value with pratical strategies in each organization. Some of these questions revealed themselves of little interest by the logic that each analysed laboratory is inserted. The research had as base the use of interviews with directors and managers of both enterprises, besides the given information got from articles and scientific publications. In the analyse of the diversification strategies practices, the analitic categories allowed to take as base the study for a better understanding and comparison with the two companies. The conclusions make us believe that questions such as: powerful market and economy market, financial aspects and types and degress present strong influency in the divertification strategies having values created for these enterprises, however each one has presented similar particularities and other ones quite different making us believe that adopted strategies do not take or go on straight route in a corporative universe. Also, it is proposed in this work for future studies concerned to the pression of the Brazilian Pharmaceutic Enterprises and how the govern intends to act over the public political to a greater development and autonomy in Brazil. |
id |
FGV_58accad8cc4a99bc52cf23c8eab733dc |
---|---|
oai_identifier_str |
oai:repositorio.fgv.br:10438/6670 |
network_acronym_str |
FGV |
network_name_str |
Repositório Institucional do FGV (FGV Repositório Digital) |
repository_id_str |
3974 |
spelling |
Almeida, André MarinhoEscolas::EBAPESobral, FilipeAlves, Paulo Vicente dos SantosMotta, Paulo Roberto2010-06-10T14:42:59Z2010-06-10T14:42:59Z2010-05-04ALMEIDA, André Marinho. Estratégias corporativas: diversificação com criação de valor estudo de caso de duas empresas farmacêuticas brasileiras. Dissertação (Mestrado em Gestão Empresarial) - FGV - Fundação Getúlio Vargas, Rio de Janeiro, 2010.http://hdl.handle.net/10438/6670As one can see the pharmaceutic market has been showing a rather competitive and rich profile on account of different questions that involve economics, financial marketing aspects, researches and development not only relate to the population health, but it is gifted by high profits and the dominancy in most multinational enterprises in the Brazilian scenary. This study brings as a proposal to analyse two Brazilian laboratories and their ways in accomplishing the diversification strategy on their business and avaliating the creation of value with pratical strategies in each organization. Some of these questions revealed themselves of little interest by the logic that each analysed laboratory is inserted. The research had as base the use of interviews with directors and managers of both enterprises, besides the given information got from articles and scientific publications. In the analyse of the diversification strategies practices, the analitic categories allowed to take as base the study for a better understanding and comparison with the two companies. The conclusions make us believe that questions such as: powerful market and economy market, financial aspects and types and degress present strong influency in the divertification strategies having values created for these enterprises, however each one has presented similar particularities and other ones quite different making us believe that adopted strategies do not take or go on straight route in a corporative universe. Also, it is proposed in this work for future studies concerned to the pression of the Brazilian Pharmaceutic Enterprises and how the govern intends to act over the public political to a greater development and autonomy in Brazil.Como se pode perceber, o mercado farmacêutico apresenta um perfil bastante competitivo e rico em diversos aspectos como o econômico, financeiro, de marketing, pesquisas e desenvolvimento, e não só para a saúde da população, ele é contemplado por altos lucros e dominado por grande parte de empresas multinacionais no cenário brasileiro. Este estudo analisa dois laboratórios brasileiros nacionais e suas formas de realizar a estratégia de diversificação em seus negócios, avaliando a criação de valor com as estratégias praticadas em cada organização. Essas questões se revelam no mínimo interessantes pela lógica que cada laboratório analisado está inserido. A pesquisa teve como base a utilização de entrevistas com diretores e gerentes de ambas as empresas, além dos dados obtidos de artigos e publicações científicas. Na análise das práticas das estratégias de diversificação, as categorias analíticas permitiram melhor compreensão e comparação com as duas companhias estudadas. As conclusões mostram que, questões como poder de mercado, economias de escopo, aspectos financeiros e tipos e graus de diversificação apresentam forte influência nas estratégias de diversificação com a criação de valor para essas empresas. No entanto, essas empresas analisadas apresentaram algumas particularidades semelhantes, e outras bastante diferentes, levando a crer que as estratégias adotadas não seguem caminhos retos no universo corporativo. Também são abordados neste trabalho, para futuros estudos, o interesse e a pressão das multinacionais em desejar adquirir empresas farmacêuticas brasileiras e a atuação do governo na política pública de maior desenvolvimento e autonomia no Brasil.porEstratégias de diversificaçãoCriação de valorIndústria farmacêuticaStrategies of diversificationValue creationPharmaceutical industryAdministração de empresasDiversificação na indústria - Estudo de casosIndústria farmacêutica - Estudo de casosPlanejamento estratégico - Estudo de casosEstratégias corporativas: diversificação com criação de valor estudo de caso de duas empresas farmacêuticas brasileirasinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisreponame:Repositório Institucional do FGV (FGV Repositório Digital)instname:Fundação Getulio Vargas (FGV)instacron:FGVinfo:eu-repo/semantics/openAccessORIGINALAndré Marinho.pdfAndré Marinho.pdfapplication/pdf1329369https://repositorio.fgv.br/bitstreams/9070bd13-70cb-4f26-b363-5fa7a667cccc/download50655f9a09d23d9111e8da3d075e40e2MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-84712https://repositorio.fgv.br/bitstreams/90ad78b5-78ff-4589-88ea-8b8d4584062e/download4dea6f7333914d9740702a2deb2db217MD52TEXTAndré Marinho.pdf.txtAndré Marinho.pdf.txtExtracted texttext/plain103180https://repositorio.fgv.br/bitstreams/9c771185-00f5-4588-9aad-ac4f28ad3885/download98e5347f448611a5eb9ad8ebe58e9285MD57THUMBNAILAndré Marinho.pdf.jpgAndré Marinho.pdf.jpgGenerated Thumbnailimage/jpeg1805https://repositorio.fgv.br/bitstreams/cc1ba472-847c-4c18-a68f-1465c02b2db0/downloade6f58f355b42d6146c8f39aef4af9d9bMD5810438/66702023-11-08 13:59:10.276open.accessoai:repositorio.fgv.br:10438/6670https://repositorio.fgv.brRepositório InstitucionalPRIhttp://bibliotecadigital.fgv.br/dspace-oai/requestopendoar:39742023-11-08T13:59:10Repositório Institucional do FGV (FGV Repositório Digital) - Fundação Getulio Vargas (FGV)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 |
dc.title.por.fl_str_mv |
Estratégias corporativas: diversificação com criação de valor estudo de caso de duas empresas farmacêuticas brasileiras |
title |
Estratégias corporativas: diversificação com criação de valor estudo de caso de duas empresas farmacêuticas brasileiras |
spellingShingle |
Estratégias corporativas: diversificação com criação de valor estudo de caso de duas empresas farmacêuticas brasileiras Almeida, André Marinho Estratégias de diversificação Criação de valor Indústria farmacêutica Strategies of diversification Value creation Pharmaceutical industry Administração de empresas Diversificação na indústria - Estudo de casos Indústria farmacêutica - Estudo de casos Planejamento estratégico - Estudo de casos |
title_short |
Estratégias corporativas: diversificação com criação de valor estudo de caso de duas empresas farmacêuticas brasileiras |
title_full |
Estratégias corporativas: diversificação com criação de valor estudo de caso de duas empresas farmacêuticas brasileiras |
title_fullStr |
Estratégias corporativas: diversificação com criação de valor estudo de caso de duas empresas farmacêuticas brasileiras |
title_full_unstemmed |
Estratégias corporativas: diversificação com criação de valor estudo de caso de duas empresas farmacêuticas brasileiras |
title_sort |
Estratégias corporativas: diversificação com criação de valor estudo de caso de duas empresas farmacêuticas brasileiras |
author |
Almeida, André Marinho |
author_facet |
Almeida, André Marinho |
author_role |
author |
dc.contributor.unidadefgv.por.fl_str_mv |
Escolas::EBAPE |
dc.contributor.member.none.fl_str_mv |
Sobral, Filipe Alves, Paulo Vicente dos Santos |
dc.contributor.author.fl_str_mv |
Almeida, André Marinho |
dc.contributor.advisor1.fl_str_mv |
Motta, Paulo Roberto |
contributor_str_mv |
Motta, Paulo Roberto |
dc.subject.por.fl_str_mv |
Estratégias de diversificação Criação de valor Indústria farmacêutica |
topic |
Estratégias de diversificação Criação de valor Indústria farmacêutica Strategies of diversification Value creation Pharmaceutical industry Administração de empresas Diversificação na indústria - Estudo de casos Indústria farmacêutica - Estudo de casos Planejamento estratégico - Estudo de casos |
dc.subject.eng.fl_str_mv |
Strategies of diversification Value creation Pharmaceutical industry |
dc.subject.area.por.fl_str_mv |
Administração de empresas |
dc.subject.bibliodata.por.fl_str_mv |
Diversificação na indústria - Estudo de casos Indústria farmacêutica - Estudo de casos Planejamento estratégico - Estudo de casos |
description |
As one can see the pharmaceutic market has been showing a rather competitive and rich profile on account of different questions that involve economics, financial marketing aspects, researches and development not only relate to the population health, but it is gifted by high profits and the dominancy in most multinational enterprises in the Brazilian scenary. This study brings as a proposal to analyse two Brazilian laboratories and their ways in accomplishing the diversification strategy on their business and avaliating the creation of value with pratical strategies in each organization. Some of these questions revealed themselves of little interest by the logic that each analysed laboratory is inserted. The research had as base the use of interviews with directors and managers of both enterprises, besides the given information got from articles and scientific publications. In the analyse of the diversification strategies practices, the analitic categories allowed to take as base the study for a better understanding and comparison with the two companies. The conclusions make us believe that questions such as: powerful market and economy market, financial aspects and types and degress present strong influency in the divertification strategies having values created for these enterprises, however each one has presented similar particularities and other ones quite different making us believe that adopted strategies do not take or go on straight route in a corporative universe. Also, it is proposed in this work for future studies concerned to the pression of the Brazilian Pharmaceutic Enterprises and how the govern intends to act over the public political to a greater development and autonomy in Brazil. |
publishDate |
2010 |
dc.date.accessioned.fl_str_mv |
2010-06-10T14:42:59Z |
dc.date.available.fl_str_mv |
2010-06-10T14:42:59Z |
dc.date.issued.fl_str_mv |
2010-05-04 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
format |
masterThesis |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
ALMEIDA, André Marinho. Estratégias corporativas: diversificação com criação de valor estudo de caso de duas empresas farmacêuticas brasileiras. Dissertação (Mestrado em Gestão Empresarial) - FGV - Fundação Getúlio Vargas, Rio de Janeiro, 2010. |
dc.identifier.uri.fl_str_mv |
http://hdl.handle.net/10438/6670 |
identifier_str_mv |
ALMEIDA, André Marinho. Estratégias corporativas: diversificação com criação de valor estudo de caso de duas empresas farmacêuticas brasileiras. Dissertação (Mestrado em Gestão Empresarial) - FGV - Fundação Getúlio Vargas, Rio de Janeiro, 2010. |
url |
http://hdl.handle.net/10438/6670 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional do FGV (FGV Repositório Digital) instname:Fundação Getulio Vargas (FGV) instacron:FGV |
instname_str |
Fundação Getulio Vargas (FGV) |
instacron_str |
FGV |
institution |
FGV |
reponame_str |
Repositório Institucional do FGV (FGV Repositório Digital) |
collection |
Repositório Institucional do FGV (FGV Repositório Digital) |
bitstream.url.fl_str_mv |
https://repositorio.fgv.br/bitstreams/9070bd13-70cb-4f26-b363-5fa7a667cccc/download https://repositorio.fgv.br/bitstreams/90ad78b5-78ff-4589-88ea-8b8d4584062e/download https://repositorio.fgv.br/bitstreams/9c771185-00f5-4588-9aad-ac4f28ad3885/download https://repositorio.fgv.br/bitstreams/cc1ba472-847c-4c18-a68f-1465c02b2db0/download |
bitstream.checksum.fl_str_mv |
50655f9a09d23d9111e8da3d075e40e2 4dea6f7333914d9740702a2deb2db217 98e5347f448611a5eb9ad8ebe58e9285 e6f58f355b42d6146c8f39aef4af9d9b |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional do FGV (FGV Repositório Digital) - Fundação Getulio Vargas (FGV) |
repository.mail.fl_str_mv |
|
_version_ |
1810023697544642560 |